Screener/Healthcare/Biotechnology

KNSA

Kiniksa Pharmaceuticals, Ltd.NASDAQ
$44.98-1.06 (-2.30%)
Mid CapUnder $50HealthcareFastest GrowingLow Beta
$18.25
$49.12
$44.43
$45.75
EPS (TTM)$0.75
P/E Ratio59.97
Dividend Yield—
Market Cap$3.42B
Volume265K
Prev Close$46.04
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$202.1M$14.2M$0.1889.6%7.0%
Q3 '25$180.9M$18.4M$0.2388.8%10.2%
Q2 '25$156.8M$17.8M$0.2388.1%11.4%
Q1 '25$137.8M$8.5M$0.1187.0%6.2%
Q4 '24$122.5M-$8.9M$-0.1285.4%-7.3%
Q3 '24$112.2M-$12.7M$-0.1882.1%-11.3%
Q2 '24$108.6M-$3.9M$-0.0688.7%-3.6%
Q1 '24$79.9M-$17.7M$-0.2586.7%-22.2%
Get Your Daily Market Recap